The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases. Alzheimer’s Disease, GLP-1 RAs (Drug), Novo Nordisk A/S, Clinical Trials, Brain, Research Read More
Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
